We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Says FDA’s OxyContin Decision Is Overdue; GOP Leaders Applaud Move
GPhA said the FDA’s decision Tuesday on abuse-deterrent OxyContin has been a long time coming and finally gives its member companies direction on how to manufacture a generic version of the blockbuster pain drug.